126 related articles for article (PubMed ID: 2896361)
1. Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing rats.
Steele TD; Bryant HU; Malven PV; Yim GK
Pharmacol Biochem Behav; 1988 Mar; 29(3):541-5. PubMed ID: 2896361
[TBL] [Abstract][Full Text] [Related]
2. Assessment of dynorphin-A depletion in the anorexia of Walker-256 tumor bearing rats.
Yim GK; Bryant HU; Malven PV
Physiol Behav; 1985 Jul; 35(1):117-20. PubMed ID: 2865763
[TBL] [Abstract][Full Text] [Related]
3. The effect of ovariectomy, estradiol and progesterone on opioid modulation of feeding.
Morley JE; Levine AS; Grace M; Kneip J; Gosnell BA
Physiol Behav; 1984 Aug; 33(2):237-41. PubMed ID: 6150505
[TBL] [Abstract][Full Text] [Related]
4. The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
Morley JE; Levine AS; Gosnell BA; Kneip J; Grace M
Physiol Behav; 1983 Nov; 31(5):603-6. PubMed ID: 6320237
[TBL] [Abstract][Full Text] [Related]
5. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
[TBL] [Abstract][Full Text] [Related]
6. Increased central serotonergic activity associated with nocturnal anorexia induced by Walker 256 carcinoma.
Nichols M; Maickel RP; Yim GK
Life Sci; 1983 Apr; 32(16):1819-25. PubMed ID: 6188015
[TBL] [Abstract][Full Text] [Related]
7. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
Shearman GT; Schulz R; Schiller PW; Herz A
Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
[TBL] [Abstract][Full Text] [Related]
8. Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat.
Tepperman FS; Hirst M
Pharmacol Biochem Behav; 1982 Dec; 17(6):1141-4. PubMed ID: 6298827
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2% sodium chloride imbibition on various opiate related hyperphagic conditions.
Bryant HU; Lowy MT; Malven PV; Steele TD; Yim GK
Pharmacol Biochem Behav; 1985 Sep; 23(3):391-5. PubMed ID: 2864702
[TBL] [Abstract][Full Text] [Related]
10. Opiates and medial hypothalamic knife cuts cause hyperphagia through different mechanisms.
Gosnell BA; Romsos DR; Morley JE; Levine AS
Behav Neurosci; 1985 Dec; 99(6):1181-91. PubMed ID: 3038141
[TBL] [Abstract][Full Text] [Related]
11. Plasma and brain cholecystokinin levels in cancer anorexia.
Chance WT; van Lammeren FM; Chen MH; Chen WJ; Murphy RF; Joffe SN; Fischer JE
J Surg Res; 1984 May; 36(5):490-8. PubMed ID: 6587166
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition by propranolol of feeding induced in rats by various stimuli.
Bryant HU; Malven PV; Yim GK
Pharmacol Biochem Behav; 1984 Oct; 21(4):651-4. PubMed ID: 6095326
[TBL] [Abstract][Full Text] [Related]
13. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
[No Abstract] [Full Text] [Related]
14. Regulation of feeding behaviour in monosodium glutamate (MSG) treated mice.
Ma V; Ma A; Cameron DP
Life Sci; 1988; 42(15):1419-24. PubMed ID: 2832677
[TBL] [Abstract][Full Text] [Related]
15. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
16. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
Periyasamy S; Hoss W
Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
Bunn SJ; Hanley MR; Wilkin GP
Neurosci Lett; 1985 Apr; 55(3):317-23. PubMed ID: 2989733
[TBL] [Abstract][Full Text] [Related]
18. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin interaction at the kappa-opiate site.
Huidobro-Toro JP; Yoshimura K; Lee NM; Loh HH; Way EL
Eur J Pharmacol; 1981 Jun; 72(2-3):265-6. PubMed ID: 6113976
[No Abstract] [Full Text] [Related]
20. Activation of K-opiate sites by dynorphin in the myenteric plexus.
Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
